Roche Holding AG GS buy melinda
Start price
23.06.17
/
50%
€234.75
Target price
25.12.17
€272.00
Performance (%)
-10.54%
End price
25.12.17
€210.00
Summary
This prediction ended on 25.12.17 with a price of €210.00. The prediction for Roche Holding AG GS disappointed with a performance of -10.54%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Roche Holding AG GS | - | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
According to melinda what are the pros and cons of Roche Holding AG GS for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Roche Holding AG NV diskutieren
Rock
Roche Holding AG: Neue Daten ocrevus von ean zeigen Rock (Ocrelizumab) haben erheblich reduziert die vielfältigen Maßnahmen der Krankheitsprogression bei schub und primären und Multiple Sklerose.
(Laufzeit überschritten)
Stopped prediction by melinda for Roche Holding AG GS
Roche Holding AG GS
Start price
Target price
Perf. (%)
€240.20
23.05.19
23.05.19
€300.00
04.11.21
04.11.21
2.44%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Roche Holding AG GS
Start price
Target price
Perf. (%)
€200.10
21.01.18
21.01.18
€244.00
23.07.18
23.07.18
3.85%
23.07.18
23.07.18
Could be worthwhile Investment >10% per year
Roche Holding AG GS
Start price
Target price
Perf. (%)
€234.75
23.06.17
23.06.17
€272.00
25.12.17
25.12.17
-10.54%
25.12.17
25.12.17
Could be worthwhile Investment >10% per year
Roche Holding AG GS
Start price
Target price
Perf. (%)
€226.81
28.06.16
28.06.16
€260.00
28.12.16
28.12.16
-4.01%
28.12.16
28.12.16
Could be worthwhile Investment >10% per year